Hidden cancer risks for Hysterectomy and Fibroid Removal
Posted in Drug & Medical Devices on July 10, 2015
Uterine cancer is the fourth most common cancer in women in the United States and the most commonly diagnosed gynecologic cancer. Prior to a hysterectomy or fibroid removal (myomectomy), the FDA estimates that approximately 1 in 350 women have an unsuspected uterine sarcoma, a type of uterine cancer that includes leiomyosarcoma. Stages of Endometrial...
J&J Pulls Hysterectomy Tool Due to Cancer Risk
Posted in Drug & Medical Devices on August 1, 2014
Johnson & Johnson has asked all hospitals to return a surgical device that can spread cancer in women being treated for uterine growths called fibroids. The company has instituted a voluntary “worldwide market withdrawal” of the surgical tool known as a laparoscopic power morcellator. During laparoscopic hysterectomies and myomectomies, surgeons use a power morcellator...
Decongestants May Cause Birth Defects
Posted in Drug & Medical Devices, Medical Malpractice on July 23, 2013
A new study reveals that using over-the-counter decongestants during pregnancy may increase the risk of a child being born with birth defects. Scientists at the Slone Epidemiology Center at Boston University interviewed nearly 20,000 mothers to find out what drugs they had taken while they were pregnant. What they found was a link between...